期刊文献+

柯萨奇病毒B组3型VP1基因真核表达重组质粒诱导小鼠中和抗体反应

Neutralizing antibody response induced by a recombinant eukaryotic expressing plasmid of Coxsackievirus group B type 3 VP1 gene
下载PDF
导出
摘要 以构建的柯萨奇病毒B 组3 型(CVB3)VP1 基因的真核表达重组质粒pCEP4CVB3VP1 作为候选的基因疫苗,评价其诱导小鼠产生的中和抗体反应。大量制备并提纯pCEP4CVB3VP1 DNA,用其接种BALB/C小鼠,取血清进行病毒中和试验。结果证明其可诱导小鼠机体产生特异性中和抗体,并能中和CVB3 毒力,起到基因疫苗的预防作用。 Being a candidate of gene vaccine,pCEP4 CVB3VP1,a recombinant eukaryotic expressing plasmid of Coxsackie virus group B type 3 VP1 gene had already been constructed by ourselves.The neutralizing antibody response elicited by pCEP4 CVB3VP1 was expected to know.A quantity of pCEP4 CVB3VP1 DNA was prepared and purified.Sera harvested from mice inoculated with pCEP4 CVB3VP1 was applied for neutralization test.The result showed that pCEP4 CVB3VP1 could induce the mice producing a specific neutralizing antibody which can neutralize the virulence of CVB3.So the inoculation of pCEP4 CVB3VP1 may be equivalent to that of a vaccine.
出处 《哈尔滨医科大学学报》 CAS 1999年第5期333-335,共3页 Journal of Harbin Medical University
基金 国家自然科学基金 黑龙江省自然科学基金
关键词 柯萨奇病毒 中和抗体 pCEP4-CVB3VP1 CVB3 Coxsackievirus group B type 3 recombinant eukaryotic expressing plasmid neutralizing antibody
  • 相关文献

参考文献4

二级参考文献21

  • 1Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Ertgl J Med 1997; 336:973 - 9.
  • 2Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C - reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke 2001 ; 32:2575 - 2579.
  • 3OnoN, Koyama T, Suehiro A, et al. Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients. Stroke 1991 ;22:1369 -73.
  • 4Schaarrsschmidt H, Prange HW, Reiber H. Neuron specific enolase concentration in blood as a prognostic parameter in cerebrovascular disease. Stroke I994; 25:558.
  • 5Wunderlich MT, Ebert AD, Kraz T, et al. Early neuronbehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30 (6): 1190-1.
  • 6Dempfle CE, Argiriou S, Kuche K, et al. Analysis of fibrin formation and proteolysis during intravenous administration of ancrod. Blood 2000; 96(8): 2793 -802.
  • 7刘秀琴.重新评估脑梗死的降纤治疗[J].中华神经科杂志,2000,33(5):263-263.
  • 8Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, andthe risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973 - 9
  • 9Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C - reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke 2001; 32: 2575 -2579
  • 10OnoN, Koyama T, Suehiro A, et al. Clinical significance of new coagulation and fibrinolvtic markers in ischemic stroke patients. Stroke 1991:22:1369 -73

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部